+1 (800) 559-9921
Enhanced Precision Kits for Quantitative Proteomics
PeptiQuant™ Plus
These kits offer our widest panels — each kit includes multiplexed assays for up to 270 proteins in human plasma or 375 proteins in mouse plasma.
The PeptiQuant™ Plus Proteomics kits provide a thorough MRM-MS strategy with paired labeled and unlabeled peptide standards to ensure robust, reproducible, and interference-free measurements. These easy-to-use kits enable you to perform precise protein quantitation using your own in-house LC-MS/MS instrumentation. Whether you’re interested in cancer, CVD, or other research areas, our carefully selected panels are able to assist your research needs.
Technology
Paired heavy/light peptide quantitation strategy
PeptiQuant™ Plus Proteomics Kits
PeptiQuant™ Plus Proteomics Kit for Human Plasma
PeptiQuant™ Plus Proteomics Kit for Mouse Plasma
Uses high quality MRM-MS technology to simultaneously quantify up to 270 human or 125 mouse proteins from a single plasma sample! Comprehensive internal standards ensure accurate quantitation. The panel includes medium to low abundance proteins associated with cancer, CVD, and other diseases.
Features
Our largest protein panel yet. Simultaneously quantify up to 270 proteins from a single plasma sample!
Available for human or mouse plasma
Available for a wide variety of triple quadrupole mass spectrometers
Panel includes low abundance proteins associated with cancer, CVD, and other diseases
High quality MRM-MS technology, with all assays characterized according to Tier II CPTAC guidelines
High purity paired heavy/light peptide standards for every targeted protein
Compatible with sample volumes as low as 10 µl of plasma
A complete turnkey solution for quantitative proteomics
Each kit includes
Heavy SIS and light peptide standard mixes
Includes BSA and trypsin
Quality control samples
Kit Manual with all required SOPs
USB with all required acquisition methods and worklists for selected instrument
Analysis instructions with Skyline templates for automated data analysis
How to order
PeptiQuant™ Plus kits can be ordered directly through our online shop as well as through our partner Cambridge Isotope Laboratories Inc.
Our complementary line of quality control products will help to ensure that your proteomics workflow and instrumentation is up to standard for every sample you analyze.
PeptiQuant™ Plus technology is also offered in a full-service format, allowing for quantitation of up to 375 proteins in a single multiplexed analysis.
ASSOCIATED REFERENCES
Jun 2018
Michaud SA, Sinclair NJ, Petrošová H, Palmer AL, Pistawka AJ, Zhang S, Hardie DB, Mohammed Y, Eshghi A, Richard VR, Sickmann A, Borchers CH
May 2017
LeBlanc A, Michaud SA, Percy AJ, Hardie DB, Yang J, Sinclair NJ, Proudfoot JI, Pistawka A, Smith DS, Borchers CH
Dec 2016
Percy AJ, Yang J, Chambers AG, Mohammed Y, Miliotis T, Borchers CH
Sep 2016
Percy AJ, Michaud SA, Jardim A, Sinclair NJ, Zhang S, Mohammed Y, Palmer AL, Hardie DB, Yang J, LeBlanc AM, Borchers CH
Sep 2016
Mohammed Y, Bhowmick P, Smith DS, Domanski D, Jackson AM, Michaud SA, Malchow S, Percy AJ, Chambers AG, Palmer A, Zhang S, Sickmann A, Borchers CH
Dec 2015
Percy AJ, Mohammed Y, Yang J, Borchers CH
Read more about what makes our technology unique.
Shop for kits, request more information, or read our FAQ.
PeptiQuant™ kits not quite right for you? Let us take care of analysis with our PeptiQuant™ services.
Targeted mass spectrometry assays were characterized at the UVic-Genome BC Proteomics Centre according to the National Cancer Institute’s Clinical Proteomic Tumor Analysis Consortium (CPTAC) assay characterization guidelines (https://assays.cancer.gov/guidance-document). Initial characterization data (produced in a human plasma matrix), can be viewed on the CPTAC Assay Portal (https://assays.cancer.gov). Note: Specific kits may use a different type of matrix from the human plasma that was used to generate the CPTAC fit-for-purpose characterization data, and thus assay performance from this kit may vary from that reported on the CPTAC Assay Portal. The CPTAC assay characterization guidance documents were developed as a direct outcome of a workshop (Carr et al., Mol Cell Proteomics 2014; PMID 24443746) sponsored by the CPTAC program.
